PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 80 filers reported holding PROMETHEUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $134,150 | -11.3% | 1,250 | -9.1% | 0.00% | – |
Q4 2022 | $151,250 | +84.5% | 1,375 | -2.2% | 0.00% | – |
Q3 2022 | $82,000 | +530.8% | 1,406 | +197.3% | 0.00% | – |
Q2 2022 | $13,000 | -94.2% | 473 | -92.0% | 0.00% | – |
Q1 2022 | $224,000 | -4.7% | 5,948 | -0.2% | 0.00% | – |
Q4 2021 | $235,000 | – | 5,962 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 1,848,024 | $203,282,640 | 93.46% |
CHI Advisors LLC | 923,800 | $101,618,000 | 27.06% |
Sio Capital Management, LLC | 574,200 | $63,162,000 | 23.36% |
Cormorant Asset Management, LP | 2,090,000 | $229,900 | 15.38% |
Boxer Capital, LLC | 1,897,500 | $208,725,000 | 11.00% |
SEVEN GRAND MANAGERS, LLC | 20,105 | $2,211,550 | 10.34% |
Decheng Capital Management III (Cayman), LLC | 250,000 | $27,500,000 | 10.29% |
Ikarian Capital, LLC | 288,926 | $31,781,860 | 7.67% |
RTW INVESTMENTS, LP | 3,354,303 | $368,973,330 | 7.53% |
Waypoint Capital Advisors, LLC | 171,181 | $18,829,910 | 6.53% |